- Our Company
- OXFAB® Technology
- OsteoFab® Technology
- OsteoFab® Medical Devices
- Contract Manufacturing
- News & Events
OPM Press Releases
August 19th, 2014
Oxford Performance Materials, Inc. (OPM), a leading advanced materials and additive manufacturing (3D printing) company, has been named the “Best Global Company for 3D Healthcare Innovation” by The New Economy Awards. The New Economy Awards, presented by The New Economy Magazine, identify and celebrate innovative companies that are breaking new ground in the areas of technology, energy, business and strategy.
August 19th, 2014
Oxford Performance Materials, Inc. (OPM), a leading advanced materials and additive manufacturing (3D printing) company, today announced that it has received 510(k) clearance from the FDA for its 3D printed OsteoFab® Patient-Specific Facial Device (OPSFD). OPM’s facial device is the first and only FDA cleared 3D printed polymeric implant for facial indications, and follows FDA clearance of the first and only 3D printed polymeric implant, OPM’s OsteoFab Patient-Specific Cranial Device, which was granted in February 2013.
August 4th, 2014
Oxford Performance Materials, Inc. (OPM), a leading advanced materials and additive manufacturing (3D printing) company, today announced the appointment of Severine Zygmont and Paul Martin as Presidents of OPM Biomedical and OPM Aerospace & Industrial divisions, respectively.
September 9th, 2013
Oxford Performance Materials (OPM) is pleased to announce the creation of a new manufacturing facility in South Windsor, CT. The facility is in close proximity to OPM’s current headquarters and manufacturing facility. This region of Connecticut, long known for its advanced subtractive manufacturing technologies, is now rapidly becoming a global leader in additive manufacturing.
July 29th, 2013
Oxford Performance Materials (OPM) is very pleased to announce that it has received a contract from Northrop Grumman Systems Corporation (NGSC) for the development of its OXPEKK® polymer for use in aerospace applications. OPM shall undertake the production of test specimens and prototype components that will allow for the establishment of a structural design database. Such a database is a necessary requirement for the design of aerospace and other critical structures.
April 8th, 2013
Oxford Performance Materials (OPM) and Biomet Microfixation (Biomet) have entered into an exclusive distribution agreement for OPM’s OsteoFab™ Patient Specific Cranial Device (OPSCD). Under the terms of the agreement, Biomet will have exclusive global distribution rights to the OPSCD and OsteoFab™ implants for craniomaxillofacial (CMF).
February 18th, 2013
Oxford Performance Materials (OPM) is pleased to announce it has received FDA 510(k) clearance for the OsteoFab™ Patient Specific Cranial Device (OPSCD). “OsteoFab” is OPM’s brand for Additively Manufactured medical and implant parts produced from PEKK polymer. With OPM’s Additive Manufacturing process (also called “3D Printing”), implants are “grown” layer by layer directly from a digital CAD file without the aid of tooling and with few practical limits on what can be produced. FDA clearance of this device marks the first approval for an additively manufactured polymer implant.
August 22nd, 2012
Oxford Performance Materials has been selected as part of a team to participate in the National Additive Manufacturing Innovation Institute (NAMII). NAMII is the pilot institute for the National Network for Manufacturing Innovation (NNMI), the initiative announced by President Obama in March 2012. OPM will work as part of a larger team of universities, companies, and organizations led by the National Center for Defense Manufacturing and Machining (NCDMM).
July 30th, 2012
Oxford Performance Materials (OPM) has acquired the rights to modify and advance the Structured Light Scanning (SLS) system developed by Connecticut Center for Advanced Technology, Inc. (CCAT). The technology was designed by CCAT under a U.S. Air Force research contract to produce 100% optical measurement of highly complex, light-weight, efficient structures. OPM is at the forefront of creating such complex structures via additive manufacturing in both biomedical and industrial markets.
November 29th, 2011
Oxford Performance Materials is pleased to announce that an innovative spinal device made from OXPEKK®-IG has recently received regulatory approvals in two South American countries. Following great success in Europe, the FILL-SQUALE™ cervical cage has been approved for long-term implantation by ANMAT and DIGEMID, the regulatory authorities in Argentina and Peru, respectively.
There are no articles posted this month.